Amgen Inc.
AMGN
$269.00
-$3.05-1.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.87B | 8.72B | 8.15B | 8.04B | 7.12B |
| Total Other Revenue | 276.00M | 370.00M | 352.00M | 347.00M | 329.00M |
| Total Revenue | 8.15B | 9.09B | 8.50B | 8.39B | 7.45B |
| Cost of Revenue | 2.61B | 712.00M | 3.31B | 3.24B | 2.51B |
| Gross Profit | 5.54B | 8.37B | 5.19B | 5.15B | 4.94B |
| SG&A Expenses | 1.69B | 1.88B | 1.63B | 1.79B | 1.81B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 30.00M | 65.00M | 64.00M | -2.00M | 37.00M |
| Total Operating Expenses | 5.81B | 4.38B | 6.45B | 6.47B | 5.70B |
| Operating Income | 2.34B | 4.71B | 2.05B | 1.92B | 1.75B |
| Income Before Tax | 1.97B | 782.00M | 3.10B | 794.00M | -68.00M |
| Income Tax Expenses | 243.00M | 155.00M | 271.00M | 48.00M | 45.00M |
| Earnings from Continuing Operations | 1.73B | 627.00M | 2.83B | 746.00M | -113.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.73B | 627.00M | 2.83B | 746.00M | -113.00M |
| EBIT | 2.34B | 4.71B | 2.05B | 1.92B | 1.75B |
| EBITDA | 3.73B | 5.99B | 3.45B | 3.32B | 3.15B |
| EPS Basic | 3.22 | 1.17 | 5.27 | 1.39 | -0.21 |
| Normalized Basic EPS | 1.93 | 5.00 | 1.62 | 0.64 | 1.32 |
| EPS Diluted | 3.20 | 1.16 | 5.22 | 1.38 | -0.21 |
| Normalized Diluted EPS | 1.92 | 4.95 | 1.60 | 0.63 | 1.32 |
| Average Basic Shares Outstanding | 538.00M | 537.00M | 537.00M | 537.00M | 536.00M |
| Average Diluted Shares Outstanding | 541.00M | 542.00M | 542.00M | 541.00M | 536.00M |
| Dividend Per Share | 2.38 | 2.25 | 2.25 | 2.25 | 2.25 |
| Payout Ratio | 73.93% | 192.19% | 42.76% | 162.06% | -1,069.03% |